Strong scientific evidence promoting cannabis as a safe therapy for those in pain or suffering from post-traumatic stress disorder is still lacking
Two recent reports, published by the United States Department for Veteran Affairs in the Annals of Internal Medicine Journal, have reviewed the integration of medical cannabis as a useful tool for the management of pain and PTSD.
Due to the fact that more and more people worldwide turn to this type of therapy to alleviate their suffering, and as many as 8 states in the United States of America have legalized it for both recreational and medicinal use, more research was necessary in order to make significant advances.
But, “little comprehensive and critically appraised information exists about the benefits and harms of using cannabis to treat chronic pain,” note the authors of the reports, as the evidence of alleviating pain was considered to be insufficient. Moreover, marijuana use can elevate the risk of psychosis, cognitive decline and street accidents.
The results are controversial because pain is defined as a complex mix of “behavioral, emotional, and cognitive domains,” and can be extremely difficult to rate. When talking about chronic pain alleviation, the use of medical cannabis is yet to be studied. In addition, also the use of medicinal marijuana “in treating PTSD symptoms remains uncertain.”
The conclusions were drawn after examining reviews, trials and research focusing on Canabis Sativa plant-based treatments of pain and PTSD. The data extracted was considered to be insufficient.
On the other hand, some medical professionals suggest a “growing consensus in the field,” with more research in the future, as well as a more relaxed legislation in targeted the countries, so that the medical staff and patients can both study the effects.